WiSys to distribute $1 million in research funds ( Madison Wis. - The growing body of ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

WiSys to distribute $1 million in research funds

Madison, Wis. - The growing body of university research under development beyond the confines of the University of Wisconsin-Madison could grow at an even faster pace as the result of a $1 million allocation approved Friday by University of Wisconsin System presidents and the Wisconsin Alumni Research Foundation.

Full article >>>

Source:wistechnology.com By Chris Fleissner and Joe Vanden Plas 06/19/06

Page: 1 2 3 4
Related biology technology :

1. WiSys to patent Marshfield Clinic discoveries
2. WiSys new manager plans system-wide research awareness
3. Microsoft to distribute $224M as part of settlement
4. WiCell, California firm agree to distribute stem cell lines derived with new technique
5. GE Healthcare to distribute stem cell harvester
6. GenTel to distribute cancer research tool
7. Musicnotes strikes deal to distribute Sony/ATV sheet music
8. Kodak to distribute Cedara mammography medical imaging software
9. EraGen cystic fibrosis test to be distributed worldwide through Bayer
10. Venture Investors early-stage fund grows to $115 million
11. Two convicted of selling $6 million in counterfeit Rockwell software on eBay

Post Your Comments:

Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5 AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3 ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3 Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2 Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3

[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology [0] ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis [0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia [0] Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures

Other Biology Technology:Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 2 Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 3 AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor 2 AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor 3

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor

Breaking Biology News(10 mins):Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 3 $2.4 million stimulus fuels effort to regenerate injured spinal cords 4 Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2 ThermoGenesis Announces National Institute of Health Grant 4576 1 ThermoGenesis Announces National Institute of Health Grant 4576 2 ThermoGenesis Announces National Institute of Health Grant 4576 3 ThermoGenesis Announces National Institute of Health Grant 4576 4 MU study finds connection between evolution classroom learning 8764 1 MU study finds connection between evolution classroom learning 8764 2 Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI 1002 in Chronic Kidney Disease at the RNA Interference Su 48292 1 Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI 1002 in Chronic Kidney Disease at the RNA Interference Su 48292 2 Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI 1002 in Chronic Kidney Disease at the RNA Interference Su 48292 3 Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI 1002 in Chronic Kidney Disease at the RNA Interference Su 48292 4

[0] Researchers demonstrate nanoscale X-ray imaging of bacterial cells [0] $2.4 million stimulus fuels effort to regenerate injured spinal cords [0] Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences

Other Biology News:First 'atlas' of key brain genes could speed research on cancer, neurological diseases 2 Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 2 Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 3 Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2 Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3

First 'atlas' of key brain genes could speed research on cancer, neurological diseases Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery

Biology Products:

Mouse IR Cytokine Array 12plex from Pierce Biotechnology, Inc.* Quick & Easy Conditional Knock Out Kit - FRT from Gene Bridges GmbH Agencourt AMPure 60ml Kit from Agencourt Bioscience EasySep Neg Mouse Combo Starter Kit from StemCell Technologies, Inc.